Afatinib in Patients with Fanconi Anemia (FA) and Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(2 sites)
Germany
Medizinische Hochschule Hannover, Hanover Spain
Hospital de la Santa Creu i Sant Pau, Barcelona, Catalonia Age range
18 Years and older
Last updated November 2024